Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China.
Saved in:
| Title: | Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China. |
|---|---|
| Authors: | Xiang QY; Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China., Wu JS; Department of Hematology, The Second Clinical Medical College of Jinan University, Shenzhen, China., Huang L; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medicine Sciences, Southern Medial University, Guangzhou, China., Zou ZK; Department of Pathology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China., Liu TB; Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China., Peng ZG; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, China., Lin LE; Department of Hematology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China., Wei XL; Department of Hematology, Nanfang Hospital and Southern Medical University, Guangzhou, China., Zhang HY; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China., Lin Y; Department of Hematology, Fujian Provincial Hospital, Fuzhou, China., Li GW; Department of Hematology, Huizhou Central People's Hospital, Huizhou, China., Jiang YR; Department of Hematology, Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China., Wang H; Department of Hematology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China., Shi KQ; Department of Hematology, The First People's Hospital of Yunnan Province, Kunming, China., Zheng RJ; Department of Hematology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China., Han ZJ; Department of Hematology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China., Qiu X; Department of Hematology, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China., Li WY; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China., Zhou JH; Department of Hematology, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital of Southern University of Science and Technology), Shenzhen, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jun 10; Vol. 15, pp. 1580370. Date of Electronic Publication: 2025 Jun 10 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
